Literature DB >> 8338722

Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.

N Dubois1, F Lapicque, M Abiteboul, P Netter.   

Abstract

Equilibrium dialysis was used to study in vitro the enantioselective binding of R, S, and racemic ketoprofen at physiological pH and temperature in human serum albumin (HSA) (1, 20, and 40 g/liter) and in plasma. The binding of enantiomers in a racemic mixture was studied to see the effect of each isomer on the other's interaction with the protein. The free fractions were determined by high-performance liquid chromatography. The binding of ketoprofen enantiomers to albumin was enantioselective, depending on both drug and protein concentrations. Enantioselectivity was observed in plasma too but was the opposite of that in HSA at 40 g/liter. The percentage of each isomer unbound was higher in the racemic mixture than with the isomer alone. The displacement of probes specific for HSA sites I and II, studied by spectrofluorimetry, suggests that all three preparations of ketoprofen are bound mainly to site I and secondarily to site II.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338722     DOI: 10.1002/chir.530050305

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  8 in total

1.  Prediction of sustained fetal toxicity induced by ketoprofen based on PK/PD analysis using human placental perfusion and rat toxicity data.

Authors:  Shingo Tanaka; Takeshi Kanagawa; Kazuo Momma; Satoko Hori; Hiroki Satoh; Takeshi Nagamatsu; Tomoyuki Fujii; Tadashi Kimura; Yasufumi Sawada
Journal:  Br J Clin Pharmacol       Date:  2017-07-27       Impact factor: 4.335

Review 2.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.

Authors:  F Lapicque; N Muller; E Payan; N Dubois; P Netter
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

4.  Parenteral delivery of HPβCD: effects on drug-HSA binding.

Authors:  Sergey V Kurkov; Thorsteinn Loftsson; Martin Messner; Donna Madden
Journal:  AAPS PharmSciTech       Date:  2010-07-24       Impact factor: 3.246

Review 5.  Clinical pharmacokinetics of dexketoprofen.

Authors:  M J Barbanoj; R M Antonijoan; I Gich
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains.

Authors:  Da Shi; Yin-xiu Jin; Yi-hong Tang; Hai-hong Hu; Si-yun Xu; Lu-shan Yu; Hui-di Jiang; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2012-05       Impact factor: 6.150

7.  Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs.

Authors:  Katja Mustonen; Anneli Niemi; Marja Raekallio; Mari Heinonen; Olli At Peltoniemi; Mari Palviainen; Mia Siven; Marikki Peltoniemi; Outi Vainio
Journal:  Acta Vet Scand       Date:  2012-09-21       Impact factor: 1.695

8.  Organism-specific differences in the binding of ketoprofen to serum albumin.

Authors:  Mateusz P Czub; Alan J Stewart; Ivan G Shabalin; Wladek Minor
Journal:  IUCrJ       Date:  2022-07-16       Impact factor: 5.588

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.